Shu-yu Wu

Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection

F. Tan, Q. Xue, Shan Yang, 2022, Molecular cancer.

Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell‐free DNA fragmentomics

R. Liu, Xue Wu, Y. Shao, 2021, Hepatology.

Multi-dimensional fragmentomic assay for ultrasensitive early detection of colorectal advanced adenoma and adenocarcinoma

Xue Wu, Y. Shao, S. Cai, 2021, Journal of Hematology & Oncology.

Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing

Yang Xu, Xue Wu, Y. Shao, 2021, Neoplasia.

Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer

Yi-long Wu, Xue Wu, Y. Shao, 2020, Journal for ImmunoTherapy of Cancer.

Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2017, Clinical Cancer Research.

Genetic and clonal dissection of osteosarcoma progression and lung metastasis

Jingnan Shen, Jin Wang, Gang Huang, 2018, International journal of cancer.